R. Di Paola, E. Esposito, E. Mazzon et al., "3,5-Dicaffeoyl-4- malonylquinic acid reduced oxidative stress and inflammation in a experimental model of inflammatory bowel disease," Free Radical Research, vol. 44, no. 1, pp. 74-89, 2010....
The present invention refers to the attainment of a natural caffeine derivative, never yet identified, 3,5-dicaffeoyl-4-malonylquinic acid, its use in human and veterinary therapy and for nutritional, cosmetic and pharmaceutical purposes. Said compound may be produced, in industrial quantities, ...